Hirota, Akira
Shoji, Jun
Inada, Noriko
Adachi, Rumi
Tonozuka, Yukiko
Yamagami, Satoru
Article History
Received: 16 January 2023
Accepted: 22 April 2023
First Online: 25 April 2023
Declarations
:
: This study was approved by the Institutional Review Board of the Nihon University Itabashi hospital (approval number: RK-190709–2) and written informed consent was obtained from all patients enrolled in this study.
: Written informed consent was obtained from the patient for publication of this study and any accompanying images. A copy of the written consent is available for review by the Editor of this journal. All study participants approved the manuscript for publication.
: J.S. has previously received honoraria from Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co., Ltd., AbbVie GK, and Rohto Nitten Co., Ltd., outside the submitted work. H.A., Y.S., N.I., Y.T., and R.A. declare that they have no conflicts of interest.